All In Biotech

Drug Trial Radar · NCT03960801

Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle Relaxant

Assessment of Remifentanil for Rapid Sequence Induction and Intubation in Full Stomach Patient Compared to Muscle Relaxant. A Non-inferiority Simple Blind Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Apr 27, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,150 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,150

Actual

Start

Oct 9, 2019

Primary completion

Apr 22, 2021

Study completion Apr 22, 2021

Sponsor

Lead sponsor
Nantes University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 23, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

REMICrush is a French multicentric non inferiority simple blind randomized clinical trial that will compare the use of Remifentanil to muscle relaxant (reference treatment) for anesthetic rapid sequence intubation in terms of major complications (difficult intubation, gastric liquid aspiration, desaturation, hemodynamics reaction, ventricular arrhythmia, anaphylactic reaction).

Conditions

  • Intra-tracheal Intubation

Interventions

  • Remifentanil groupDrug

    bolus intravenous injection of 3 to 4µg/kg of remifentanil after hypnotic administration for a crush anesthetic induction

  • neuromuscular blockade groupDrug

    Bolus intravenous injection of 1mg/kg of Succinylcholine or Rocuronium after hypnotic administration for a crush anesthetic induction

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of tracheal intubation without major complicationTime frame: Day 7 from randomization

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • University Hospital

    Angers, France

  • Military Hospital

    Brest, France

  • University Hospital

    Brest, France

  • University Hospital

    Grenoble, France

  • CHD Vendée

    La Roche-sur-Yon, France

  • Hospital

    Le Mans, France

  • University hospital (SALENGRO hospital)

    Lille, France

  • University Hospital

    Lille, France

  • University Hospital Lyon Sud

    Lyon, France

  • Le Confluent

    Nantes, France

  • University Hospital

    Nantes, France

  • Toulouse University Hospital

    Toulouse, France

  • Hospital

    Valenciennes, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.